This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Galena Biopharma Inc (GALE)

NASDAQ: Health Care

Company Profile
Price and Volume
Recent Price 0.73
52 Week High 2.39
52 Week Low 0.59
Avg. Daily Vol. (Mil) 1.53
Beta (3 year) 1.49
Share Related Items
Mkt Cap (Mil) 118.42
Shares Out (Mil) 161.91
Float (Mil) 161.15
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.90
Current Ratio 1.50
LT Debt/ Equity 0.05
Total Debt / Equity 0.18
Valuation Ratios
Price Earnings n.a.
Price/Sales 12.70
Price/Book 3.65
Price/Cash Flow -2.30
Per Share Data
Earnings -0.35
Sales 0.06
Book Value 0.20
Cash Flow -0.32
Business Summary
Galena Biopharma Inc, is a biopharmaceutical company focused on developing and commercializing targeted oncology therapeutics that address medical needs across the full spectrum of cancer care.
General Information
4640 South West Macadam Aven
Suite 270
Portland, OR 97239
www.galenabiopharma.com
Industry : Drugs
Sector: Health Care
Employees: 57
CEO: Dr. Mark W. Schwartz, Ph
Short Interest
Current Month (Mil) 18.03
Previous Month (Mil) 19.54
Short Interest Ratio (Days) 7.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -63.10
Return on Investments -153.70
Profitability
Gross Margin 83.10
EBIT Margin n.a.
Profit Margin 0.00
GALE News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

GALE Galena Biopharma Inc

Chart of GALE

Analysts Ratings for GALE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 5 5 5
Moderate Buy 1 1 1 1
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
GET GALE ANALYST REPORT

GALE Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs